Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2020

01-12-2020 | Diabetic Retinopathy | Research article

Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus

Authors: Atsuki Kume, Kenji Kashiwagi

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Diabetic macular edema (DME) causes severe vision loss among patients with diabetes mellitus (DM). We aimed to investigate systemic and ocular diseases associated with the development of DME in a Japanese population.

Methods

A total of 3.11 million Japanese subjects who were registered in the database of the Japan Medical Data Center from 2005 to 2014 were analyzed. Subjects with DM were defined as individuals who had been prescribed any therapeutic medications for DM, and associated diseases were analyzed. The periods assessed were one year before the development of DME among patients with DME and one year before the last visit to an ophthalmic clinic among patients without DME.

Results

A total of 17,403 patients with DM satisfied the inclusion and exclusion criteria, and 420 patients developed DME. Univariate analysis revealed significant associations between 55 diseases, including 39 systemic and 16 ocular diseases, and DME development. Logistic analysis identified 21 systemic diseases and 10 ocular diseases as significant factors associated with DME development.

Conclusion

Various types of systemic and ocular diseases are associated with DME development. Subjects with DM who present these risk factors must be carefully monitored to prevent visual impairment.
Appendix
Available only for authorised users
Literature
1.
Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290(15):2057–60..PubMed
2.
Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298(8):902–16.PubMed
3.
Klein R, Klein BK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: ii. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520–6.PubMed
4.
Leske MC, Wu S-Y, Hyman L, Li X, Hennis A, Connell AMS, Schachat AP. Diabetic retinopathy in a black population: the Barbados eye study. Ophthalmology. 1999;106(10):1893–9.PubMed
5.
Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community: the blue mountains eye study. Ophthalmology. 1998;105(3):406–11.PubMed
6.
West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R, Snyder R. Diabetes and diabetic retinopathy in a Mexican-American population. Proyecto VER. 2001;24(7):1204–9.
7.
Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley diabetes study. Diabetes. 1989;38(10):1231–7.PubMed
8.
Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346–54.PubMed
9.
Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–63.PubMed
10.
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen S-J, Dekker JM, Fletcher A, Grauslund J, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.PubMedPubMedCentral
11.
Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Arrieta-Blanco FJ, Gomez-Campelo P. Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One. 2013;8(10):e76417.PubMedPubMedCentral
12.
Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592–6.PubMedPubMedCentral
13.
Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool diabetic eye study: a cohort study. Lancet. 2003;361(9353):195–200.PubMed
14.
Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, Moreno-Ribas A, Valls-Mateu A, Sagarra-Alamo R, Barrot-De La Puente JF, Mundet-Tuduri X. Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study. J Diabetes Res. 2018;2018:5637130.PubMedPubMedCentral
15.
Martin-Merino E, Fortuny J, Rivero-Ferrer E, Garcia-Rodriguez LA. Incidence of retinal complications in a cohort of newly diagnosed diabetic patients. PLoS One. 2014;9(6):e100283.PubMedPubMedCentral
16.
17.
Wang S, Wang JJ, Wong TY. Alcohol and eye diseases. Surv Ophthalmol. 2008;53(5):512–25.PubMed
18.
Sasaki M, Kawashima M, Kawasaki R, Uchida A, Koto T, Shinoda H, Tsubota K, Wang JJ, Ozawa Y. Association of Serum Lipids with Macular Thickness and Volume in type 2 diabetes without diabetic macular edema. Invest Ophthalmol Vis Sci. 2014;55(3):1749–53.PubMed
19.
Conway BN, Miller RG, Klein R, Orchard TJ. Prediction of proliferative diabetic retinopathy with hemoglobin level. Arch Ophthalmol. 2009;127(11):1494–9.PubMedPubMedCentral
20.
Yang J-K, Liu W, Shi J, Li Y-B. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care. 2010;33(5):1018–20.PubMedPubMedCentral
21.
Klein BK, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol. 2009;127(9):1175–82.PubMedPubMedCentral
22.
Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17.
23.
Liu E, Craig JE, Burdon K. Diabetic macular oedema: clinical risk factors and emerging genetic influences. Clin Exp Optom. 2017;100(6):569–76.PubMed
24.
Kume A, Ohshiro T, Sakurada Y, Kikushima W, Yoneyama S, Kashiwagi K. Treatment patterns and health care costs for age-related macular degeneration in Japan: an analysis of National Insurance Claims Data. Ophthalmology. 2016;123(6):1263–8.
25.
Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413–9.PubMedPubMedCentral
26.
Kashiwagi K, Furuya T. Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Jpn J Ophthalmol. 2014;58(1):68–74.PubMed
27.
Sloan FA, Belsky D, Ruiz D Jr, Lee P. Changes in incidence of diabetes mellitus–related eye disease among us elderly persons, 1994-2005. Arch Ophthalmol. 2008;126(11):1548–53.PubMedPubMedCentral
28.
Diep TM, Tsui I. Risk factors associated with diabetic macular edema. Diabetes Res Clin Pract. 2013;100(3):298–305.PubMed
29.
Varma R, Bressler NM, Doan QV, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(11):1334–40.PubMedPubMedCentral
30.
Kayýkçýolu Ö, Özmen B, Seymenoglu G, Tunalı D, Kafesçiler SÖ, Güclü F, Hekimsoy Z. Macular edema in unregulated type 2 diabetic patients following glycemic control. Arch Med Res. 2007;38(4):398–402.PubMed
31.
Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, Kaynak S. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018;18(1):91.PubMedPubMedCentral
32.
Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497–503.PubMedPubMedCentral
33.
Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev Ophthalmol. 2010;47:148–59.PubMed
34.
Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114(5):881–9.PubMed
35.
36.
Yamamoto M, Fujihara K, Ishizawa M, Osawa T, Kaneko M, Ishiguro H, Matsubayashi Y, Seida H, Yamanaka N, Tanaka S, et al. Overt proteinuria, moderately reduced eGFR and their combination are predictive of severe diabetic retinopathy or diabetic macular edema in diabetes. Invest Ophthalmol Vis Sci. 2019;60(7):2685–9.PubMed
37.
Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses' health study. Diabetes Care. 2006;29(7):1573–8.PubMed
38.
Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care. 2007;30(4):835–41.PubMed
39.
Cawood EH, Bancroft J, Steel JM. Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med. 1993;10(5):444–8.PubMed
40.
Tentolouris A, Thanopoulou A, Tentolouris N, Eleftheriadou I, Voulgari C, Andrianakos A, Sfikakis PP. Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus. Ann Transl Med. 2018;6(20):399.PubMedPubMedCentral
41.
Neumann J, Hofmann FC, Heilmeier U, Ashmeik W, Tang K, Gersing AS, Schwaiger BJ, Nevitt MC, Joseph GB, Lane NE, et al. Type 2 diabetes patients have accelerated cartilage matrix degeneration compared to diabetes free controls: data from the osteoarthritis initiative. Osteoarthr Cartil. 2018;26(6):751–61.PubMedPubMedCentral
42.
Arellano Perez Vertti RD, Aguilar Muniz LS, Moran Martinez J, Gonzalez Galarza FF, Arguello Astorga R. Cartilage Oligomeric matrix protein levels in type 2 diabetes associated with primary knee osteoarthritis patients. Genet Test Mol Biomarkers. 2019;23(1):16–22.PubMed
43.
Dubey NK, Ningrum DNA, Dubey R, Deng YH, Li YC, Wang PD, Wang JR, Syed-Abdul S, Deng WP. Correlation between Diabetes Mellitus and Knee Osteoarthritis: A Dry-To-Wet Lab Approach. Int J Mol Sci. 2018;19(10):3021.
44.
Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230–5.PubMed
45.
Hwang IC, Lee YJ, Ahn HY, Lee SM. Association between allergic rhinitis and metabolic conditions: a nationwide survey in Korea. Allergy Asthma Clin Immunol. 2016;12:5.PubMedPubMedCentral
46.
Browning DJ, Fraser CM, Clark S. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology. 2008;115(3):533–9 e532.PubMed
47.
Graham PS, Kaidonis G, Abhary S, Gillies MC, Daniell M, Essex RW, Chang JH, Lake SR, Pal B, Jenkins AJ, et al. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy. BMC Med Genet. 2018;19(1):71.PubMedPubMedCentral
48.
Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun. 2005;333(3):679–85.PubMed
49.
El-Shazly SF, El-Bradey MH, Tameesh MK. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes. Clin Exp Ophthalmol. 2014;42(4):369–78.PubMed
50.
Kaidonis G, Burdon KP, Gillies MC, Abhary S, Essex RW, Chang JH, Pal B, Pefkianaki M, Daniell M, Lake S, et al. Common sequence variation in the VEGFC gene is associated with diabetic retinopathy and diabetic macular edema. Ophthalmology. 2015;122(9):1828–36.PubMed
51.
Abhary S, Burdon KP, Casson RJ, Goggin M, Petrovsky NP, Craig JE. Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol. 2010;128(1):102–6.PubMed
Metadata
Title
Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus
Authors
Atsuki Kume
Kenji Kashiwagi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01578-8

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue

Research article

Short-time evaluation on intraocular scattering after implantable collamer lens implantation for correcting high myopia

Case report

Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2

Correspondence

Response to correspondence from Koerner and colleagues concerning our paper entitled: The effect of diluting povidone-iodine on bacterial growth associated with speech

Technical advance

Ab interno implantation of glaucoma drainage devices tubes in the posterior chamber

Case report

CT and MRI findings in relapsing primary malignant melanoma of the lacrimal sac: a case report and brief literature review

Case report

Acute bilateral myopia induced by Triplixam: a case report